Who Paid My Doc
A Master Protocol to Investigate the Efficacy and Safety of Ly3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity Or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (Triumph-1)
ClinicalTrials.gov NCT05929066
Research payments
$24,570,573
Through program year 2025, $24,570,573 in research payments was reported against A Master Protocol to Investigate the Efficacy and Safety of Ly3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity Or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (Triumph-1), across 238 payments.
- Paid by (largest first)
- Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
- ClinicalTrials.gov
- NCT05929066
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $10,065,683 | 98 |
| 2024 | Research | $14,394,574 | 137 |
| 2023 | Research | $110,316 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Daniel Bessesen Denver, CO Named on 8 payments
- Michael Woolman Ogden, UT Named on 6 payments
- John Hudson Austin, TX Named on 6 payments
- Mark Kutner Miami, FL Named on 6 payments
- Ronald Mayfield Greenville, SC Named on 5 payments
- Tatyana Miroshnikova Orlando, FL Named on 4 payments
- Susan Brian Topeka, KS Named on 4 payments
- Louise Taber Phoenix, AZ Named on 4 payments
- Cindy Pau Honolulu, HI Named on 4 payments
- Alan Kivitz Duncansville, PA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.